Tirzepatide is a high-purity research-only peptide studied for its dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This peptide is utilized in laboratory research focused on metabolic regulation, endocrine signaling, and peptide-receptor interaction pathways.

Tirzepatide is designed for researchers investigating dual incretin signaling mechanisms and their influence on glucose-related pathways, energy balance, and metabolic signaling in controlled research environments.

Key Research Characteristics

Tirzepatide – A dual GIP and GLP-1 receptor agonist studied for its interaction with incretin receptors and downstream metabolic and endocrine signaling pathways.

Research Focus Areas

• Dual incretin receptor signaling pathways

• Metabolic and endocrine regulation research

• Peptide-receptor interaction studies

• Energy balance and glucose-related signaling

Quality & Specifications

• High-purity Tirzepatide (≥99%)

• Lyophilized for laboratory stability

• Independently tested for identity and purity

• Manufactured in controlled research-grade facilities

Important Notice

For Research Use Only.

This product is not intended for human or animal consumption, clinical use, or diagnostic purposes. Intended exclusively for qualified researchers conducting laboratory research.